Screener
ImmunityBio, Inc. IBRX Net gains (losses) on investments
Net gains (losses) on investments at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by ImmunityBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:UnrealizedGainLossOnInvestments.
The source filing: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 7:37 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001326110-26-000059
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Non-cash investing and financing activities: | ||
| Conversion of related-party convertible note into equity | 35,332 | — |
| Issuance of common stock upon vesting of RSUs | 16,379 | 2,995 |
| Right-of-use assets obtained in exchange for operating lease liabilities | 1,721 | — |
| Property and equipment purchases included in accounts payable, accrued expenses and due to related parties | 1,406 | 1,107 |
| Unrealized losses on marketable debt securities, net | (180) | (11) |
| Unpaid offering costs included in accounts payable and accrued expenses | 136 | — |
| Unpaid RIPA issuance costs included in accrued expenses | 54 | — |
ITEM 1. FINANCIAL STATEMENTS.
FAQ
- What is ImmunityBio, Inc.'s net gains (losses) on investments?
- ImmunityBio, Inc. (IBRX) reported net gains (losses) on investments of -$180K in Q1 2026.
- How has ImmunityBio, Inc.'s net gains (losses) on investments changed year-over-year?
- ImmunityBio, Inc.'s net gains (losses) on investments decreased by 1536.4% year-over-year, from -$11K to -$180K.
- What is the long-term trend for ImmunityBio, Inc.'s net gains (losses) on investments?
- Over 4 years (2021 to 2025), ImmunityBio, Inc.'s net gains (losses) on investments has grown at a -100.0% compound annual growth rate (CAGR), from -$4.62M to $0.
- What does net gains (losses) on investments mean?
- Realized and unrealized gains/losses on investments removed from operating cash flow since they're investing-related.
Ask your AI about ImmunityBio, Inc.'s net gains (losses) on investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude